Fortis Capital Management LLC Amgen Inc Transaction History

Fortis Capital Management LLC

$495 Million
Q3 2024

A detailed history of Fortis Capital Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Fortis Capital Management LLC holds 1,664 shares of AMGN stock, worth $490,097. This represents 0.11% of its overall portfolio holdings.

Number of Shares

1,664

Previous 1,648 0.97%

Holding current value

$490,097

Previous $514,000 4.28%

% of portfolio

0.11%

Previous 0.11%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$309.38 - $337.38 $4,950 - $5,398	16 Added 0.97%	1,664 $536,000
Q2 2024 Jul 23, 2024	BUY	$262.75 - $319.31 $18,918 - $22,990	72 Added 4.57%	1,648 $514,000
Q1 2024 Apr 30, 2024	BUY	$268.87 - $324.56 $3,495 - $4,219	13 Added 0.83%	1,576 $448,000
Q4 2023 Feb 12, 2024	BUY	$255.7 - $288.46 $3,068 - $3,461	12 Added 0.77%	1,563 $450,000
Q3 2023 Nov 03, 2023	BUY	$218.65 - $271.46 $2,842 - $3,528	13 Added 0.85%	1,551 $416,000
Q2 2023 Aug 04, 2023	BUY	$214.27 - $253.37 $3,214 - $3,800	15 Added 0.98%	1,538 $341,000
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $2,935 - $3,577	13 Added 0.86%	1,523 $368,000
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $2,290 - $2,910	10 Added 0.67%	1,510 $396,000
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $2,693 - $3,037	12 Added 0.81%	1,500 $338,000
Q2 2022 Aug 10, 2022	BUY	$230.71 - $256.74 $2,768 - $3,080	12 Added 0.81%	1,488 $362,000
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $113,753 - $126,201	-487 Reduced 24.81%	1,476 $360,000
Q1 2021 Apr 21, 2021	BUY	$221.91 - $258.6 $108,070 - $125,938	487 Added 32.99%	1,963 $488,000
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $279,273 - $358,963	1,476 New	1,476 $356,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortis Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortis Capital Management LLC with notifications on news.

Account

Fortis Capital Management LLC Amgen Inc Transaction History